2020
DOI: 10.1111/aor.13705
|View full text |Cite
|
Sign up to set email alerts
|

The influence of left ventricular assist device inflow cannula position on thrombosis risk

Abstract: The use of left ventricular assist devices (LVADs) as a treatment method for heart failure patients has been steadily increasing; however, pathological studies showed presence of thrombi around the HeartWare ventricular assist device inflow cannula (IC) in more than 95% of patients after device explantation. Flow fields around the IC might trigger thrombus formation and require further investigation. In this study flow dynamics parameters were evaluated for different patient geometries using computational flui… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
30
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(30 citation statements)
references
References 43 publications
0
30
0
Order By: Relevance
“…For the HeartMate II LVAD, a narrow angle between the inflow cannula and pump body is associated with pump thrombosis 8 . For the HeartWare LVAD (Medtronic, Minneapolis, MN), a narrow cannula coronal angle is associated with improved left ventricular (LV) unloading and adverse outcomes 9,10 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…For the HeartMate II LVAD, a narrow angle between the inflow cannula and pump body is associated with pump thrombosis 8 . For the HeartWare LVAD (Medtronic, Minneapolis, MN), a narrow cannula coronal angle is associated with improved left ventricular (LV) unloading and adverse outcomes 9,10 …”
Section: Introductionmentioning
confidence: 99%
“…8 For the HeartWare LVAD (Medtronic, Minneapolis, MN), a narrow cannula coronal angle is associated with improved left ventricular (LV) unloading and adverse outcomes. 9,10 Although there are no reports among the HeartMate 3 LVAD cohort, the knowledge of appropriate device positioning might make it easier to achieve optimal hemodynamics which is associated with reduced rates of HF readmission and HRAEs. [11][12][13] In this study, we investigated the association between HeartMate 3 device position, cardiac unloading, and clinical outcomes.…”
mentioning
confidence: 99%
“…Accordingly, if the recovery from LVAD is the best perspective in LVAD patients, monitoring intraventricular regional hemodynamics during LVAD flow reduction is mandatory to assess the restoration of a normal pattern, although this approach is never applied. In fact, it is known that adaptation to flows in the presence or absence of the cannula determines favorable conditions to the thrombi’s formation, even after the explant has taken place 18 . Furthermore, many other factors such as cannula material and surface characteristics, as well as the patients' coagulation status may be of some clinical significance, explaining the differences observed in the flow field 19 …”
Section: Restoration Of Left Ventricular Performancementioning
confidence: 99%
“…In fact, it is known that adaptation to flows in the presence or absence of the cannula determines favorable conditions to the thrombi's formation, even after the explant has taken place. 18 Furthermore, many other factors such as cannula material and surface characteristics, as well as the patients' coagulation status may be of some clinical significance, explaining the differences observed in the flow field. 19 We believe that, once the stabilization and well-being of patients have been achieved, major efforts should be made to progressively and slowly reduce LVAD pump flow, allowing the restoration of left ventricular performance.…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4][5] Thrombosis around the VAD inlet cannula (IC) has been recently highlighted as a possible source of ischemic stroke events in patients receiving a left ventricular assist device (LVAD). 6,7 In fact, the potential role of the ventricular cannula in thrombosis-related complications has motivated numerical, in vitro, and clinical studies for over two decades. [7][8][9][10][11][12][13][14] The majority of studies have concentrated on the intraventricular flow dynamics, specifically in the region of the ventricular apex, but have neglected the many biochemical factors involved in the coagulation cascade.…”
Section: Introductionmentioning
confidence: 99%